Information For Authors

Mary Ann Liebert, Inc. Submission Benefits Package

Your submission to AIDS Research and Human Retroviruses provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:

  • Rapid, rigorous peer-review and editorial attention
  • Immediate deposit to PubMed and other indexing services upon online publication
  • Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
  • Fast Track online-ahead-of-print publication
  • Global availability in over 170 countries
  • Open Access publication options

Submitting Your Manuscript

Click here to submit your paper via our fast and user-friendly electronic submission system.

Manuscript Revisions

To upload a revision of a paper, the submitting author should log in to their Author Center at and click on “Revised Manuscripts in Draft.”

Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments.  



Page charges for this journal are set at $70.00 USD per typeset page.  Nonpayment of page charges may result in a delay in publication.  Costs for printing images in color are a separate fee and are not included in the page charge total.


 Instructions for Authors

AIDS Research and Human Retroviruses is a peer-reviewed journal in the English language. The Journal will publish Full and Short Communications, Letters to the Editor, Perspectives, Sequence Notes, Mini-reviews, and Conference or Workshop Summaries as deemed appropriate.


Full Communications should be presented in the format described below.

Short Communications, also subject to peer-review, are intended for the presentation of brief observations that do not warrant a full-length text, but also are not preliminary results. Include an abstract; do not use section headings in the body of the text; report methods, results, and discussion in a single section. Reference citations are identical in style to those of full-length papers, but appropriately abbreviated.  These submissions should not exceed 1,200 words with no more than 10 references and one table OR figure.  The word count does not include the abstract, acknowledgments, disclosure information, references, figure legends, or tables.

Letters to the Editor(s) are welcomed, but with a 500 word limit and no more than one (1) table OR figure, and with a maximum of four (4) references.


Images in HIV Research:  Images can tell a research story and capture the imagination as well as provide scientific information about spatial relationships and context.   We welcome submissions that contain striking images that illustrate and illuminate a research story, make a timely and relevant point, emphasize a new and emerging concept, or are stunning and beautiful.

Submission Requirements:

  • Text should be no more than 500 words
  • Limit of four references
  • Images must be uploaded at a minimum of 300 DPI. 
  • Images must be in either .TIFF or .EPS files.  .JPEG files cannot be used as the resolution of these files is too low.

Images may be considered for use on the Journal cover in the issue the submission is published.

All submissions are subject to peer review.  All accepted submissions will be deposited to Medline after final publication.

Letters to the Editor can be on any issue relevant to the field of human retroviruses. They must be brief (one or two journal pages) and appropriately documented by data. Letters can be sent to the Editor-in-Chief or to the basic science or clinical Editors, and may be subject to review.

Mini-reviews and Perspectives may be solicited by the Editors or submitted independently. Mini-reviews are brief summaries of new developments in the field of human retroviruses. Perspectives are more representative of an opinion about an area of the field or a direction of research. The length for either should not exceed seven journal pages, and both may be subject to peer-review.

Sequence Notes offer more rapid publication of papers that present novel sequence data in a brief format. They are generally no more than 3 or 4 journal pages.  Include an abstract of not more than 150 words, but do not use section headings in the text, and limit the references to 15.  Sequence Notes, like all papers, should be uploaded here.
Allow 2-3 weeks for the initial evaluation.

Senior Clinical Editor
Carlos del Rio, Professor of Medicine (Infectious Diseases), Emory Center for AIDS Research, Atlanta, Georgia

Editors - Basic Sciences

Cell Biology
Birgitta Åsjö, Centre for Research in Virology, University of Bergen, Bergen, Norway

Mario Stevenson, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA

Michael Betts, University of Pennsylvania, Philadelphia, PA

Animal Models
Ronald C. Desrosiers, New England Regional Primate Research Center,
Southborough, MA

Molecular Biology/Other Human Retroviruses
Patrick Green, The Ohio State University, Columbus, OH

Sequence Notes
Brian Foley, HIV Sequence Database, Los Alamos National Laboratory, Los Alamos, NM

Editors - Clinical Investigations

Complications of Therapy
Mariana Gerschenson, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI

Mauro Schechter, Professor of Infectious Diseases, Head, AIDS Research Laboratory, Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil            

Thomas Hope, Ph.D., Feinberg School of Medicine, Northwestern University,  Chicago, IL



Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal. 

Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form.  It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications.


The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.

Preparation of Manuscript

Follow all submission guidelines to avoid delays in processing and publication. Type manuscripts double-spaced. Leave ample margins on the sides, top, and bottom of the page. Manuscripts should be submitted in Microsoft Word.

The title page should include the authors’ names and affiliations, and a running title of about 45 characters, including spaces. Please indicate contact information for the corresponding author, including a mailing and/or street address, telephone and fax numbers, and e-mail address. The second page must consist of an abstract of not more than 250 words, which should be self-explanatory without reference to the text. Full communications are structured using the following headings: abstract, introduction, materials and methods, results, discussion, acknowledgments, sequence data, and references. Number pages consecutively. At the end of the manuscript, give the name and address of the individual to whom reprint requests should be directed. The inclusion of that person’s e-mail address is also strongly encouraged.

The authors may suggest suitable referees in a cover letter, but must provide accurate contact information for all such individuals, including fax numbers. Please follow the requested style to avoid delays in publication.


Manuscript keywords (search terms): On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines.  These terms may or may not be different from the terms you selected for the peer review process and areas of expertise.  You will be asked to retype these search terms in the submission form when uploading your manuscript.  These keywords will be included in the published article.  If the search terms entered do not match the manuscript, the manuscript will serve as the default.


Keywords (Areas of Expertise)

To facilitate the peer review process, select 4-6 keywords from the drop-down list of pre-selected terms when submitting your manuscript.   These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.



The Journal publishes all accepted papers within 72 hours of acceptance in their unedited, uncorrected format.  It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review.  Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision of the article is published.  As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission.

The next revision will take place after the corresponding author sees page proofs, makes any necessary corrections, and returns the changes to the Publisher.  Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.

Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.


AIDS Research and Human Retroviruses has adopted the recommendations of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV) (Ref: Science 232:1486, 1986, and Nature 321:644, 1986) to designate viruses associated with AIDS. The Committee’s suggestion was to use HIV (human immunodeficiency virus) or the generic name for this class of human retroviruses. The Committee also recommended maintaining the specific strain names (LAV-1BRU, LAV-1LOI,  HTLV-IIIB,  HTLV-IIIRF,  ARV1 . . .) in the interest of continuity and appreciation for the biologic and molecular differences of the individual strains. Thus, for the sake of accuracy, the editors encourage the use of specific strain names in experimental details.

Sequence Data

AIDS Research and Human Retroviruses requires submission of accession numbers with any manuscript that uses sequence data. The numbers must be listed in a separate section following acknowledgments. Accession numbers can be obtained from Genbank, EMBL, or DDBJ. See for information, or send e-mail to


Submit each table with its title in a separate file. Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Table legends and footnotes should be double-spaced. Information that appears in the text should not be repeated in tables, and tables should not contain data that can be given in the text in one or two sentences.


Figures/images should be presented according to these guidelines:

  • Do not include any illustrations as part of your text file.
  • Do not prepare any figures in Word as they are not workable.
  • Line illustrations must be submitted at 1200 DPI.
  • Halftones and color photos should be submitted at 300 DPI.
  • Please submit either .TIFF or .EPS files.
  • Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted to CYMK, and some slight color variation may occur.
  • Do NOT submit PowerPoint or Excel files.

Color Artwork

The Journal will publish color illustrations, but the author must subsidize the cost of the color printing. For further details, contact the Publisher.


Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the References section.


All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.



All references must be cited in the text. Cite references within the text by a superscript Arabic number. Number references in the order that they appear in the text. Double-space the references and triple-space between each listing. When there are more than six authors, it is acceptable to list the first three followed by “et al.” Use the appropriate styles:

(1) surname of author(s), initials, (2) paper title, (3) journal, (4) year of publication, (5) volume number, and (6) first and last page of citation. Example: Williams N: T cells on the mucosal frontline. Science 1998;280:198–200.

(1) surname of author(s), initials, (2) chapter title, (3) title of book, (4) editors of book (if applicable), (5) edition of book (if applicable), (6) publisher, (7) city of publication, (8) year of publication, and (9) first and last page reference. Example: Bolognesi D: HIV vaccines. In: Immunology of HIV infection. (Gupta S, ed.) Plenum Medical, New York, 1996, pp. 561–576.

(1) country of original registration, (2) patent number, (3) month, day, and year of issuance.

When data from an unpublished source are presented, supply complete information, e.g., researcher’s name and location. If work is in press, give the journal in which it is to be published or the publisher.


The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the manuscript. All permissions listings must be shown in manuscript—they cannot be entered on proofs.


Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


The Journal is published monthly by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101. 

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events